TNF and inflammatory bowel disease: Those studies resulted in the approval of TNF inhibitors for adult AS, while in children and adolescents, TNF inhibitors are licensed only for polyarticular juvenile rheumatoid arthritis/juvenile idiopathic arthritis as well as inflammatory bowel disease [25-29].